Stockscreener 앱 받기
3.14
0.00%
0.00
시간 외 거래:
3.08
-0.06
-1.91%
전일 마감가:
$3.14
열려 있는:
$3.15
하루 거래량:
120.97K
Relative Volume:
0.06
시가총액:
$3.20M
수익:
-
순이익/손실:
$-6.64M
주가수익비율:
-0.0175
EPS:
-179.3009
순현금흐름:
$-5.60M
1주 성능:
-1.88%
1개월 성능:
-39.62%
6개월 성능:
-88.79%
1년 성능:
-99.07%
1일 변동 폭
$3.01
$3.22
1주일 범위
$2.92
$3.56
52주 변동 폭
$2.10
$524.00
Clearmind Medicine Inc Stock (CMND) Company Profile
Compare CMND vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CMND
Clearmind Medicine Inc
|
3.14 | 3.43M | 0 | -6.64M | -5.60M | -179.30 |
VRTX
Vertex Pharmaceuticals Inc
|
458.99 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
607.93 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
892.26 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.72 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.77 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Clearmind Medicine Inc 주식(CMND)의 최신 뉴스
Cash per share of Clearmind Medicine Inc. – FWB:CWY0 - TradingView
Tangible book value per share of Clearmind Medicine Inc. – FWB:CWY0 - TradingView
Clearmind Medicine Jumps 24.1% as Traders React to Fresh CMND-100 Updates and Upcoming June 10 Webinar - Moomoo
Clearmind Medicine Company Profile & Introduction - Moomoo
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Clearmind Medicine Inc. - MLQ.ai
CMND Stock Quote Price and Forecast - CNN
Clearmind Medicine jumps 24.1% as traders react to fresh CMND-100 updates and upcoming June 10 webinar - Quiver Quantitative
CMND Stock Jumps As Clearmind Wins Key Trial, IP Milestones - StocksToTrade
CMND Stock Jumps As Clearmind Advances Trials And Expands IP - timothysykes.com
$Clearmind Medicine (CMND.US)$ - Moomoo
Clearmind Medicine to Present CMND-100 Clinical Trial Data on June 5, 2026 - geneonline.com
Clearmind Medicine Inc. to Host Live Webinar on MEAI and Alcohol Use Disorder with Yale and Johns Hopkins on June 10, 2026 - Quiver Quantitative
Clearmind Medicine to Feature New Insights from CMND-100 Psychedelic Clinical Trial on “Inside MEAI” Webinar - marketscreener.com
Clearmind Medicine Shares On The Move With Cash Question Looming - Bez Kabli
CMND News | CLEARMIND MEDICINE INC (NASDAQ:CMND) - ChartMill
Why Did CMND Stock Jump 40% Today? - Stocktwits
CMND Technical Analysis | Trend, Signals & Chart Patterns | CLEARMIND MEDICINE INC (NASDAQ:CMND) - ChartMill
Why Taylor Morrison Home Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Sahm
Clearmind Medicine (CMND) Revenue BreakdownMain Composition - Moomoo
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Clearmind announces Japanese patent application for MEAI depression treatment By Investing.com - Investing.com South Africa
Clearmind announces Japanese patent application for MEAI depression treatment - Investing.com UK
CMND Stock Jumps As Clearmind Advances Trials And IP Push - StocksToTrade
CMND Stock Spikes As Clearmind Advances Johns Hopkins Trial - timothysykes.com
Clearmind Medicine stock surges 95% on Japan patent filing By Investing.com - Investing.com Canada
Clearmind Medicine stock surges 95% on Japan patent filing - Investing.com
Clearmind Medicine Inc. Announces Publication of Japanese Patent Application for MEAI in Depression Treatment - Quiver Quantitative
Clearmind Medicine Advances Global Intellectual Property Portfolio with Japanese Patent Filing for Innovative Psychedelic- Based Depression Treatment - The Manila Times
Clearmind Medicine(CMND) Stock Options Chain | Quotes & News - Moomoo
CMND Stock Price, Quote & Chart | CLEARMIND MEDICINE INC (NASDAQ:CMND) - ChartMill
Clearmind Medicine announces JHM-IRB approval to advance CMND-100 trial - TipRanks
Clearmind receives Johns Hopkins IRB approval for trial parts - Investing.com UK
Clearmind Medicine Advances Cmnd-100 Phase I/Ii Clinical Trial to Next Parts - marketscreener.com
Clearmind receives Johns Hopkins IRB approval for trial parts By Investing.com - Investing.com Australia
Clearmind Medicine stock gains on Johns Hopkins trial approval By Investing.com - Investing.com Nigeria
Clearmind Medicine stock gains on Johns Hopkins trial approval - Investing.com
Clearmind Medicine Announces Johns Hopkins IRB Approval to Advance CMND-100 Phase I/II Clinical Trial to the Next Parts - The Manila Times
Clearmind Medicine (Nasdaq: CMND) wins IRB nod to advance CMND-100 trial - Stock Titan
Clearmind Medicine Inc. Receives IRB Approval for Phase I/II Clinical Trial of CMND-100 in Alcohol Use Disorder - Quiver Quantitative
Cash from financing activities of Clearmind Medicine Inc. – LS:A427B1 - TradingView
Net income before discontinued operations of Clearmind Medicine Inc. – LS:A427B1 - TradingView
Clearmind Medicine Inc (CMND) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Clearmind Medicine Inc 주식 (CMND) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | 10% Owner |
Jun 10 '26 |
Buy |
0.15 |
2,159,052 |
330,335 |
2,063,266 |
| HRT FINANCIAL LP | 10% Owner |
Jun 11 '26 |
Sale |
0.12 |
225,191 |
27,698 |
1,838,075 |
2.60%
0.94%
자본화:
|
볼륨(24시간):